Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Confirming The Sitaxsentan Dose In Patients Undergoing Heart Surgery
      Description

      This is a multi-center, randomized study of sitaxsentan administered intravenously to subjects who are undergoing elective CABG, cardiac valve replacement, or combined CABG and cardiac valve replacement procedures that require CPB.

      Conditions
      Cardiac Surgery SubjectsSubjects Undergoing CABG and/or Cardiac Valve Replacement
      Talk to us